OptiBiotix Health (OPTI) Competitors GBX 17.70 -0.30 (-1.64%) As of 01/21/2025 12:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines OPTI vs. ORPH, AMPH, ANW, REVB, MRK, AURA, PHE, CYAN, OKYO, and ALTShould you be buying OptiBiotix Health stock or one of its competitors? The main competitors of OptiBiotix Health include Open Orphan (ORPH), Aggregated Micro Power (AMPH), Aberdeen New Thai Investment Trust (ANW), Revolution Beauty Group (REVB), Marks Electrical Group (MRK), Aura Energy (AURA), PowerHouse Energy Group (PHE), CyanConnode (CYAN), OKYO Pharma (OKYO), and Altitude Group (ALT). These companies are all part of the "pharmaceutical products" industry. OptiBiotix Health vs. Open Orphan Aggregated Micro Power Aberdeen New Thai Investment Trust Revolution Beauty Group Marks Electrical Group Aura Energy PowerHouse Energy Group CyanConnode OKYO Pharma Altitude Group OptiBiotix Health (LON:OPTI) and Open Orphan (LON:ORPH) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, community ranking, earnings, institutional ownership, risk and profitability. Does the media prefer OPTI or ORPH? In the previous week, OptiBiotix Health had 1 more articles in the media than Open Orphan. MarketBeat recorded 1 mentions for OptiBiotix Health and 0 mentions for Open Orphan. OptiBiotix Health's average media sentiment score of 0.18 beat Open Orphan's score of 0.00 indicating that OptiBiotix Health is being referred to more favorably in the media. Company Overall Sentiment OptiBiotix Health Neutral Open Orphan Neutral Does the MarketBeat Community favor OPTI or ORPH? OptiBiotix Health received 145 more outperform votes than Open Orphan when rated by MarketBeat users. Likewise, 59.18% of users gave OptiBiotix Health an outperform vote while only 0.00% of users gave Open Orphan an outperform vote. CompanyUnderperformOutperformOptiBiotix HealthOutperform Votes14559.18% Underperform Votes10040.82% Open OrphanOutperform VotesNo VotesUnderperform Votes2100.00% Which has stronger earnings & valuation, OPTI or ORPH? Open Orphan has higher revenue and earnings than OptiBiotix Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOptiBiotix Health£1.26M13.76-£2.98M-£0.03-590.17Open Orphan£34.71M0.00N/AN/AN/A Is OPTI or ORPH more profitable? Open Orphan's return on equity of 0.00% beat OptiBiotix Health's return on equity.Company Net Margins Return on Equity Return on Assets OptiBiotix HealthN/A -36.34% -13.93% Open Orphan N/A N/A N/A Do insiders & institutionals have more ownership in OPTI or ORPH? 4.9% of OptiBiotix Health shares are owned by institutional investors. 12.0% of OptiBiotix Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryOptiBiotix Health beats Open Orphan on 6 of the 10 factors compared between the two stocks. Get OptiBiotix Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPTI and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OPTI vs. The Competition Export to ExcelMetricOptiBiotix HealthBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£17.34M£177.42M£5.39B£2.04BDividend YieldN/A3.64%5.37%5.16%P/E Ratio-590.17131.1588.831,926.65Price / Sales13.7619,225.091,284.87384,006.48Price / Cash8.6813.0136.6029.21Price / Book2.219.234.963.08Net Income-£2.98M-£20.89M£117.89M£183.60M7 Day Performance1.93%0.40%2.75%3.09%1 Month Performance-0.25%2.27%3.63%3.42%1 Year Performance-31.24%131.63%27.26%165.41% OptiBiotix Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OPTIOptiBiotix HealthN/AGBX 17.71-1.6%N/A-31.2%£17.34M£1.26M-590.171Gap UpORPHOpen OrphanN/AN/AN/AN/A£67.09M£34.71M-25.30179AMPHAggregated Micro PowerN/AN/AN/AN/A£64.54M£49.33M70.771,620Gap UpANWAberdeen New Thai Investment TrustN/AN/AN/AN/A£63.63M£2.08M120.615REVBRevolution Beauty GroupN/AGBX 17.82-2.1%N/A-49.0%£56.89M£191.29M594.0010Positive NewsMRKMarks Electrical Group1.6612 of 5 starsGBX 54+1.0%GBX 100+85.2%-23.1%£56.53M£114.26M1,613.00200AURAAura EnergyN/AGBX 6.68-3.6%N/A-50.6%£52.75M£92,496.00-667.5050Positive NewsPHEPowerHouse Energy GroupN/AGBX 1.20+3.9%N/A+204.3%£50.19M£680,842.00-138.004Gap UpCYANCyanConnodeN/AGBX 8.60-2.3%N/A+18.1%£29.89M£18.73M-860.00100Gap UpOKYOOKYO PharmaN/AN/AN/AN/A£23.24MN/A-140.007Gap DownALTAltitude GroupN/AGBX 27+3.8%N/A-32.6%£19.57M£24.01M2,700.0050Gap DownHigh Trading Volume Related Companies and Tools Related Companies Open Orphan Alternatives Aggregated Micro Power Alternatives Aberdeen New Thai Investment Trust Alternatives Revolution Beauty Group Alternatives Marks Electrical Group Alternatives Aura Energy Alternatives PowerHouse Energy Group Alternatives CyanConnode Alternatives OKYO Pharma Alternatives Altitude Group Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:OPTI) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptiBiotix Health Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share OptiBiotix Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.